Various studies have shown that therapeutic activation of Nrf2 pathways is a key mechanism for promoting antioxidant genes and preventing neuroinflammation in major CNS diseases, including PD [72,73,74,75]. This evidence concerns the gene NFE2L2 and Parkinson disease.